volume 277, issue 1-2, P155-162 2004
DOI: 10.1016/j.ijpharm.2003.09.048
View full text
|
|
Share

Abstract: A new modality of drug targeting to tumors that is under development in our lab is based on the drug encapsulation in polymeric micelles followed by a localized release at the tumor site triggered by focused ultrasound. The rationale behind this approach is that drug encapsulation in micelles decreases systemic concentration of drug and provides for a passive drug targeting to tumors via the enhanced penetration and retention (EPR) effect, thus, reducing unwanted drug interactions with healthy tissues. In addi…

expand abstract